BioCryst

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioCryst and other ETFs, options, and stocks.

About BCRX

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases.

CEO

Jon P. Stonehouse

CEOJon P. Stonehouse

Employees

536

Employees536

Headquarters

Durham, North Carolina

HeadquartersDurham, North Carolina

Founded

1986

Founded1986

Employees

536

Employees536

BCRX Key Statistics

Market cap

914.05M

Market cap914.05M

Price-Earnings ratio

-3.80

Price-Earnings ratio-3.80

Dividend yield

—

Dividend yield—

Average volume

3.46M

Average volume3.46M

High today

$4.67

High today$4.67

Low today

$4.41

Low today$4.41

Open price

$4.59

Open price$4.59

Volume

2.73M

Volume2.73M

52 Week high

$9.07

52 Week high$9.07

52 Week low

$4.03

52 Week low$4.03

BCRX News

Yahoo Finance 12h

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c) - Yahoo Finance

BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., May 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced tha...

Simply Wall St 4d

Insufficient Growth At BioCryst Pharmaceuticals, Inc. Hampers Share Price - Simply Wall St

BioCryst Pharmaceuticals, Inc.'s ( ) price-to-sales (or "P/S") ratio of 2.6x might make it look like a strong buy right now compared to the Biotechs industry in...

Analyst ratings

83%

of 12 ratings

Buy

83.3%

Hold

16.7%

Sell